Author reply clarifies risk estimates between reclassified sarcopenic obesity groups, indicating wide confidence intervals preclude claims of equivalence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yuta Ozaki (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: